Economics research promotes malaria testing

January 9, 2013 by Matt Collette in Diseases, Conditions, Syndromes

Economics research promotes malaria testing

Enlarge

Research shows that making malaria tests available in countries like Uganda leads to more effective treatment. Credit: Thinkstock

In poor coun­tries where malaria is preva­lent but access to health care is lim­ited, many people mis­tak­enly treat the common cold or other serious ill­nesses such as pneu­monia with med­ica­tions for the mosquito-​​borne disease.

North­eastern econ­o­mist William Dickens, a Uni­ver­sity Dis­tin­guished Pro­fessor of Eco­nomics and Social Policy and a non­res­i­dent senior fellow at the Brook­ings Insti­tu­tion, and a team of researchers is trying to combat this problem. Late last year, the researchers pub­lished a sem­inal research study in the open-​​assess journal, which found that pro­viding sub­si­dies and edu­ca­tion can influ­ence more people in poor coun­tries like Uganda to get tested for . Upping the avail­ability of malaria tests increased the like­li­hood that infected people would take the appro­priate med­ica­tion and decreased the like­li­hood of taking unnec­es­sary, costly, and poten­tially harmful med­ica­tions, which are often sold at drug stores without a prescription.

Artem­i­nisin is the only avail­able drug that is broadly effec­tive against malaria, which has adapted to resist ear­lier forms of treat­ment, but it is also very expen­sive. Sub­si­dies make it pos­sible for people to pur­chase the drug, Dickens explained, but also lead to its overuse. This, in turn, can increase the cost of malaria treat­ment pro­grams and raise the risk that those who take Artem­i­nisin inap­pro­pri­ately can build par­a­site immu­nity and suffer con­se­quences from delayed treat­ment of other serious illnesses.

"The big problem right now in fighting malaria is that the par­a­sites have become resis­tant to all of the cheap old cures to malaria," Dickens said.

Sub­si­dizing the costs of malaria tests, he noted, makes them more afford­able for both drug stores and patients, and thus more acces­sible, Dickens said. He added that stores often don't pro­vide these tests if they must pay full price, citing a fear of being unable to sell them.

"Overall, we proved that you could dis­tribute the tests through the pri­vate sector," Dickens said, noting that hos­pi­tals and public health orga­ni­za­tions tra­di­tion­ally per­form the tests. "This was a very effec­tive way to get more tests out."

Dickens pre­sented the find­ings last weekend at the annual meeting of the Amer­ican Eco­nomic Asso­ci­a­tion. He hopes that the study, which was con­ducted by researchers from insti­tu­tions including North­eastern, Johns Hop­kins Uni­ver­sity, and the Har­vard School of Public Health, will help shape the poli­cies of orga­ni­za­tions such as the Global Fund and U.S. Agency for Inter­na­tional Devel­op­ment, both of which have major cam­paigns against malaria.

"These find­ings can make a very real dif­fer­ence in how global devel­op­ment orga­ni­za­tions fight malaria," he said.

Journal reference: PLoS ONE search and more info website

Provided by Northeastern University search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Ginger compounds may be effective in treating asthma symptoms

Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...

Diseases, Conditions, Syndromes created 2 hours ago | popularity not rated yet | comments 0

New research identifies practice changes to improve value and quality of GI procedures

There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).

Diseases, Conditions, Syndromes created 14 hours ago | popularity not rated yet | comments 0

Consuming coffee linked to lower risk of detrimental liver disease, study finds

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Diseases, Conditions, Syndromes created 14 hours ago | popularity not rated yet | comments 0 | with audio podcast

New case of SARS-like virus in Saudi: ministry

A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.

Diseases, Conditions, Syndromes created May 18, 2013 | popularity not rated yet | comments 0

Little evidence for prediction rules for low back pain

(HealthDay)—Few randomized clinical trials have been done to assess clinical prediction rules for patients with lower back pain, and the trials that have been done are of low quality and do not provide ...

Diseases, Conditions, Syndromes created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast


Researchers identify a potential new risk for sleep apnea: Asthma

Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...

Study finds that sleep apnea and Alzheimer's are linked

A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.

Computational tool translates complex data into simplified 2-dimensional images

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...

New theory on genesis of osteoarthritis comes with successful therapy in mice

Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

Alzheimer's leaves bilingual victims stranded in Canada

The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.